Demand for Dario’s integrated cardiometabolic solution continues to grow as employers grappling with the surge in GLP-1 medication utilization search for proven ways to change health behaviors NEW YORK, Nov. 27, 2023 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.